Last reviewed · How we verify
NCT07235371
Transcutaneous Electrical Acupoint Stimulation for Postoperative Urinary Retention After Radical Surgery for Cervical Cancer
NA trial testing transcutaneous electrical acupoint stimulation in Postoperative Urinary Retention (POUR) in 76 participants. Currently enrolling.
30 November 2028
Quick facts
| Lead sponsor | Lu Chao |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | treatment |
| Enrollment | 76 |
| Start date | 18 November 2025 |
| Primary completion | 30 November 2028 |
| Estimated completion | 30 November 2028 |
| Sites | 1 location across China |
Drugs / interventions tested
- transcutaneous electrical acupoint stimulation
- Sham transcutaneous electrical acupoint stimulation
Conditions studied
- Postoperative Urinary Retention (POUR) — all drugs for Postoperative Urinary Retention (POUR) →
Sponsor
Lu Chao
Who can join
Adults 18 to 70, female only, with Postoperative Urinary Retention (POUR). Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a prospective, blinded, single-center, randomized controlled trial. We will include 76 patients with postoperative urinary retention (POUR) after radical hysterectomy for cervical cancer who have a clear diagnosis and meet the screening criteria as the research object. They will be randomly divided into the transcutaneous electrical acupoint stimulation（TEAS）group and the sham TEAS group according to a 1:1 ratio. Each group consists of 38 patients, and all patients will be required to sign a written informed consent form. The TEAS group will be treated with TEAS based on conventional treatment, and the sham TEAS group will be treated with shamTEAS based on conventional treatment. The main outcomes will be the changes in post-void residual (PVR) volume; secondary indicators will include the response rate of participants with successful urinary catheter removal after intervention, assessment of urinary tract infection (UTI), and patient quality of life assessment according to the EORTC QLQ-C30 scale. The participants will also be evaluated with expectations, blind evaluation, compliance evaluation, and safety evaluation to preliminarily evaluate the effect of TEAS for postoperative urinary retention after radical hysterectomy for cervical cancer.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07235371
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of transcutaneous electrical acupoint stimulation
Trials testing the same drug.
- NCT07480785 — TEAS Combined With Triple Antiemetic Drugs to Prevent PONV in High-Risk Patients · NA · recruiting
- NCT07338448 — Electrical Acupoint Stimulation on Gastric Reflux During I-gel Ventilation · NA · not yet recruiting
- NCT06541561 — Efficacy of TEAS on Postoperative Pain and Recovery in Patients Undergoing Pancreatectomy · NA · not yet recruiting
- NCT06521632 — Acupoint Stimulation Improves Cognition Under Hypoxia · NA · not yet recruiting
- NCT06341270 — Efficacy of TEAS on Postoperative Pain and Recovery in Patients Undergoing Hepatectomy · NA · recruiting
Other recruiting trials for Postoperative Urinary Retention (POUR)
Currently open trials in the same condition.
- NCT06843538 — Peri-operative Tamsulosin and Impact on Voiding Trial After Same-day Urogynecology Surgery · Phase 3 · recruiting
Other Lu Chao trials
Trials by the same sponsor.
- NCT07253194 — Electroacupuncture on Postoperative Urinary Retention After Radical Surgery for Cervical Cancer · NA · not yet recruiting
- NCT06639399 — Effect of Different Acupuncture Schemes for Postoperative Urinary Retention in Cervical Cancer Patients · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07235371 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Lu Chao
- Last refreshed: 6 February 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07235371.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing